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THE EFFECTS OF HEXOESTROL AND OF "AMPHENONE B" ON MORPHOLOGY
AND FUNCTION OF THE RAT ADRENAL CORTEX
This investigation forms part of a study of the secretory capacity of the
rat's adrenal cortex after structural changes have been produced in the
gland by the administration of drugs and hormones. The two examples to
be discussed are the effects of hexoestrol' and of 'amphenone B' (1, 2-bis
(p-aminophenyl)-2 methyl-propanone-1 dihydrochloride). The latter sub-
stance, subsequently to be called 'amphenone,' was generously supplied by
Dr. R. Hertz.
The functional state of the glands was tested by collecting the venous
effluent from the left adrenal gland during anaesthesia and then carrying out
a chemical estimation of the corticosterone secreted; unlike other species,
the rat does not produce cortisol,' even after intensive treatment with
ACTH'; in this respect the rat differs from the rabbit which has been
shown to secrete cortisol after prolonged administration of ACTH.' Since,
again in contrast to the rabbit, the rat does not secrete dehydrocortico-
sterone either, corticosterone estimations are a reliable guide to the rat's
secretion of 'glucocorticoids.'
The conditions of the experiments were those of operative stress, and the
secretion was therefore approaching or equalling maximal secretory capacity
of the gland. This is shown by the fact that infusion of ACTH during such
an operation produces little further increase in hormone output. Information
on 'resting secretion' is not afforded by this technique.
METHODS
Adult male rats weighing between 250 and 400 g were used. The pre-operative
treatment consisted of either:
(a) Daily injections of 0.3-0.5, and usually 0.4 mg hexoestrol/kg, given subcutane-
ously as 0.2 per cent solution in oil, the number of injections varying between
1 and 15.
(b) Daily administration, by stomach tube, of 0.2 g amphenone/kg as 5 per cent
solution in water. The solutions were freshly prepared every 2 or 3 days, and
stored in the refrigerator.
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(c) Four daily injections of hexoestrol as under (a), followed by at least four
days in which treatments (a) and (b) were combined.
Estimation of corticosterone
The method' consisted of collecting blood from the left renal vein in a heparinized
rat anaesthetized either with urethane (1.5 g/kg) or pentobarbital (45 mg/kg). Tribu-
taries to the renal vein other than the adrenal vein were tied, and so was the entry of
the renal vein into the vena cava. The right femoral vein was cannulated so that intra-
venous injections could be given, and the blood pressure was recorded from the right
femoral artery whenever desirable.
The blood was centrifuged, the plasma extracted with organic solvents and the
purified extract chromatographed on paper with one of Bush's8 solvent systems.
Markers of pure steroids were run together with the extracts. After developing the
chromatogram, the steroids were located by U.V. absorption, and the corticosterone
was eluted with ethanol. The eluate was evaporated to dryness and the colour formed
by the residue on incubation with blue tetrazolium measured in the spectro-photometer
at 520 m,u (modification of the method of Mader and Buck'6). The possible occurrence
of substances other than corticosterone was investigated by spraying developed chroma-
tograms with a 12 per cent solution of NaOH in water containing 3 mg blue tetra-
zolium per 100 ml, drying the paper rapidly and examining the fluorescence in U.V.
light.8
RESULTS
Hexoestrol. It is well known that oestrogens in general, and stilboestrol
and hexoestrol in particular, cause a rapid loss of lipids from the adrenal
cortex'5"o; the effect is dependent on the integrity of the pituitary and per-
sists for weeks provided treatment is maintained; only after many months
may there be restitution of normal lipid content."'a The loss of lipids is
accompanied by a variable hypertrophy of the gland and an increase in
vascularity which may lead to hemorrhage; following oestradiol adminis-
tration, increased amounts of ACTH are circulating in the blood.6 The
functional state of such adrenals has been a matter of much speculation,
hyperactivity being stipulated by some, exhaustion following initial hyper-
activity by others; a third view' suggested that the hypertrophy might be
a secondary effect of excessive ACTH secretion, resulting from lack of
hormone production by an inhibited adrenal cortex. This latter hypothesis
would create an analogy between the action of thiouracil on the thyroid and
that of oestrogens on the adrenal.
Figure 1 represents the results of a group of experiments carried out in
urethane anaesthesia (left part of the figure), and another group done
under pentobarbital (right part). The secretion per min per g adrenal is
shown in black columns, and the value per single adrenal per hr per kg
body weight in white columns. After hexoestrol the secretion was severely
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depressed, both per g adrenal tissue and per kg body weight. Whereas the
secretion of normal rats was the same with both anaesthetics, the depression
by hexoestrol was more severe in urethane anaesthesia. In these experi-
ments, the shortest treatment with hexoestrol lasted 3, and the longest, 15
days. The depression ob-
30 tained was approximately the same for all durations. 140 In order to test the
26 hypothesis that the fall in
120 secretion was due to 'ex-
22 haustion by initial stimula-
loo tion,' shorter experimental
18 periods were tried. When
80 two injections were given,
14 depression was slightly less
60 than before. The experi-
^60 ments were then further 10 shortened: intervals of 24,
40 4Y2, and 3j/2 hours were
6 allowed between injection
*l | 20 of hexoestrol and cannula-
2 J tion of the renal vein. In
_ - _ * _ _ _ * . _ no instance was the secre-
CI 8 13 17 tion greater than normal,
C H C H and in two of the experi-
FIG. 1. Corticosterone secretion of rats, means and ments depression had al-
standard errors of the mean.
Left part: urethane anaesthesia. ready set in.
Right part: pentobarbital anaesthesia. When the injections of Left ordinate and black columns: Ag corticosterone/g
adrenal/min. hexoestrol were allowed
Rightordinate and white columns: lAgcorticosterone/ to lapse for a week, re-
adrenal/hr/kg bodyweight.
Number of rats under each pair of columns. covery of secretory per-
C: normal controls. formance had taken place.
H: rats given hexoestrol, 0.4 mg/kg subcutane- E
ously for 3-15 days. Experiments were also
carried out to see whether
the diminished secretion of corticosterone was indicative of genuine depres-
sion of synthesis or whether another steroid was produced which might re-
place the normal compound. This was done by carrying out the NaOH-
fluorescence test on chromatograms of plasma from rats treated with hex-
oestrol; any steroids with an a,f3-unsaturated ketone group are shown up
by this reaction.! Not only was there no new compound to be found in such
chromatograms, but the decrease in secretion of corticosterone was accom-
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panied by a decreased production of the androgen normally found in rat
adrenal blood.
Ways were then sought
thesis exerted by hexoes-
trol.' In one type of ex-
periment, the immediate
effect of various infusions
was tried (Fig. 2). Rats
were injected with hex-
oestrol for periods of 4 or
5 days, and a first 15-
minute sample of blood
collected in the usual way
from the left adrenal. Then
8 ml of different solutions
were infused, 4 ml during
the 10 minutes before, and
4 ml during the first 10
minutes of collecting a
second 15-minute sample
of adrenal blood. Some-
times collection of the pre-
infusion sample was omit-
ted. When the solution in-
fused was plasma from
normal rats, corticosterone
secretion per g adrenal re-
verted to normal figures
(Fig. 2, column 3). If in-
fusion was carried out with
the same amount of plasma
taken from rats injected
with hexoestrol for five
days, no improvement in
secretory performance en-
sued. This result pointed
to the absence of a normal
to antagonize the depression of hormone syn-
No.of513 329 6 8 4
column 1 2 3 4 5 6
FIG. 2. Corticosterone secretion of rats, means and
standard errors of the mean.
Ordinate: Ag corticosterone/g adrenal/min.
Column 1: normal rats.
Column 2: rats given hexoestrol, 0.4 mg/kg sub-
cutaneously for 4-6 days.
Columns 3-6: all rats had 4-5 injections of hexo-
estrol (0.4 mg/kg subcutaneously) and in addi-
tion:
Column 3: an infusion of 8 ml plasma from normal
rats.
Column 4: an infusion of 8 ml plasma from hex-
oestrol-pretreated rats (0.4 mg/kg for 5 days).
Column 5: an infusion of 8 ml 5% bovine albumin.
Column 6: amphenone (0.2 g/kg for 4 days by
stomach tube), while hexoestrol injections were
being continued.
plasma constituent from the blood of rats injected with hexoestrol as a pos-
sible cause of the functional deficiency of the adrenal cortex in these
animals.
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The possibility, however, existed that the beneficial effect of normal
plasma was due to a mere dilution of the hexoestrol present in the tissues;
this was ruled out by infusing another hexoestrol-free solution of about the
same colloid-osmotic pressure as plasma, a 5 per cent solution of bovine
albumin. Such infusions had the same effect on the blood pressure as had
rat plasma, but were devoid of any restorative action on cortical secretion
(Fig. 2, column 5). It may be concluded from these experiments that
hexoestrol does not produce its inhibitory effect on cortical secretion by
causing any profound damage to the enzyme systems of the cell, but by
depriving the adrenal of some substance which can be supplied by a brief
infusion of normal rat plasma.
In the search for the substance which is lacking in adrenals of rats given
hexoestrol, cholesterol suggests itself as a possibility. When hexoestrol is
administered, there is rapid loss from the cortex of sudanophilic material,
of which cholesterol is a major component; depletion persists as long as the
hexoestrol is given,18 in contrast to what happens after administration of
ACTH or in prolonged stress, where there is usually only an initial fall
followed by an accumulation of cholesterol. Plasma cholesterol is very low
after hexoestrol administration, and a lack of this precursor of adrenal
steroids in the blood would explain the beneficial effects of infusing normal
plasma to hexoestrol-treated rats, and the lack of improvement when plasma
from rats which have themselves had hexoestrol is given instead. Accord-
ing to this theory, the damaging action of hexoestrol on the rat adrenal is
exerted through an interference with cholesterol synthesis, leading to a
decrease in the available amount of a material necessary for steroid syn-
thesis. Direct support for this interpretation was obtained by Boyd and
McGuire' who demonstrated a decrease in cholesterol synthesis from C14-
labelled acetate in liver slices of rats given hexoestrol for periods of 6-13
days.
Other effects of hexoestrol can now be interpreted as a result of the inter-
ference with cholesterol synthesis. There will be increased production of
ACTH due to a lack of circulating corticosterone; this leads to hypertrophy
and hyperplasia of the adrenal cortex, and to hypertrophy of the anterior
lobe of the pituitary, if treatment is sufficiently prolonged. The condition
would thus be analogous to the response of the thyroid when antithyroid
drugs are administered.
An important question is whether this action of hexoestrol occurs in
other species including man or is restricted to the rat. Experiments on cats
and rabbits have shown that the cat is very intolerant to hexoestrol and
reacts with liver damage to rather small doses; adrenal changes were not
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produced with doses compatible with survival.' The rabbit, however,
tolerated large amounts of hexoestrol, but neither adrenal lipids, nor corti-
costerone and cortisol secretion measured in operative stress, were
decreased.'2
In man, there is as yet no evidence that adrenal histology or secretion are
affected, though influences of oestrogens on plasma cholesterol and its
transport mechanisms have been reported."" lb It is also of some interest to
TABLE 1. CORTISONE SECRETION OF MALE RATS GIVEN AMPHENONE
(0.2 G/KG) DAILY BY STOMACH TUBE
Body weight (g)
At At
start
406
330
330
334
382
320
316
end
398
308
300
285
354
279
274
Adrenal
Days weight
treated (mg/kg b.w.)
10 72
12 109
12 114
14 149
14 83
17 145
17 117
Secretion of corticosterone
sg/g ,Ag/gland/hr/kg
gland/min b.w.
32.0 137
40.3 264
40.7 278
29.4 275
19.1 95
19.8 173
28.2 199
314 10-17 113* + llt 29.9 ± 2.9t 203* + 26t
8 265 247
9 295 285
10 291 283
11 270 266
12 280 266
Mean 10-12 272
Mean 13-25 (Controls) 338
2 99
2 89
4 93
4 104
4 120
4 106* 8t
0 64 +2t
* Significantly different from controls.
t Standard error of the mean.
know whether all oestrogens act like hexoestrol. The answer to this ques-
tione is that the differences between oestrogens are quantitative, but not
qualitative.
Amphenone. In the first experiments, dosage and duration of treatment
was that recommended by Hertz et al.'0 It is clear from Table 1 that adrenal
hypertrophy was considerable after 10-17 days' feeding of amphenone; the
corticosterone secretion per g gland was high, but still within normal limits,
and, owing to the enlargement of the gland, the secretion per single adrenal
and per kg bodyweight was greatly increased. This result was very sur-
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No.
1
2
3
4
5
6
7
Mean 1-7
30.3
34.2
42.8
39.7
34.8
39.1* + 2.4t
25.1 + 1.8t
180
183
239
248
251
246* + 4t
95 +5t
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prising, particularly in view of the fact that, in man, amphenone has been
reportede to decrease the excretion of 17-hydroxycorticoids in the urine and
the level of 17-hydroxycorticoids in the plasma. In these patients, however,
treatment was never longer than two or five days, and therefore a series of
experiments of short duration was carried out in the rat.
Table 1 shows that the results were essentially the same as with the
chronic treatment. After two days, adrenal size was already increased,
secretion per g gland was on the upper limit of normal, and secretion per
kg bodyweight significantly above normal. After four days, all these effects
had progressed further, and even secretion per g gland had risen signifi-
TABLE 2. CORTISONE SECRETION OF MALE RATS BEFORE AND AFTER
INTRAVENOUS INFUSION OF AMPHENONE
9.g corticosterone secreted
Dose Duration of per g gland per min
Body infused infusion Before After Reduction
No. weight (g) (mg/kg) (min) infusion infusion in secretion (%)
1 325 50 8 32.0 13.6 58
2 318 63 7 26.4 14.5 45
3 330 58 3 37.2 23.4 37
cantly above the normal range. From this material it cannot be decided
whether there is actually a peak in the effects after a few days with some
recovery towards normal if treatment is prolonged; it is more likely that
the peak at four days was only accidental. Histologically, accumulation of
lipids and hypertrophy are noticeable after two days and go on increasing
as treatment is being continued.
These experiments do not give any information on corticoid secretion in
the unstressed state, but they show conclusively that the adrenal has a
much greater secretory capacity during stress when the rat has been fed
amphenone for 2 to 17 days than without that treatment.
Two groups of authors""had come to a similar conclusion by attempting
to carry out tests of adrenal function in rats fed with amphenone. Though
interpretation was difficult, the experiments suggested an increased rather
than a decreased capacity for secretion in these animals.
Inhibition of steroid synthesis has been reported when amphenone is
infused intravenously in the hypophysectomized dog8 or added to the per-
fusion fluid of calf adrenals." In the dogs, the response to an intravenous
injection of ACTH was inhibited, and in the calves, synthesis of cortico-
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sterone, cortisone, and cortisol was depressed, irrespective of whether
ACTH had been added to the perfusion fluid. In an attempt at finding out
whether the species or the mode of administration was responsible for the
different responses, amphenone was given intravenously to rats, one sample
of blood being collected before and one after the infusion of amphenone.
The dose was the same as that used in the hypophysectomized dogs.8
TABLE 3. CORTICOSTERONE SECRETION OF MALE RATS INJECTED FOR FOUR DAYS WITH
HEXOESTROL (0.4 MG/KG) AND THEN GIVEN AMPHENONE (0.2 G/KG)
BY MOUTH AND HEXOESTROL (0.4 MG/KG) SUBCUTANEOUSLY
Days of Adrenal Secretion of corticosterone
Body weight (g) combined weight Ag/g ug/gland/hr/kg
No. At start At end treatment (mg/kg b.w.) gland/min b.w.
1 356 340 4 90 24.5 132
2 315 295 4 116 20.2 140
3 414 352 4 89 28.3 151
4 335 303 4 100 24.1 144
5 329 260 9 154 13.3 123
6 358 280 9 110 19.3 126
7 370 282 10 106 24.2 153
8 345 268 10 115 16.2 112
9 332 263 11 133 13.6 108
10 324 270 11 96 29.2 169
11 362 287 12 176 21.2 224
Mean 12-43* (Controls*) 323 0 91.5 12.7 ± 0.46 68.6 + 6.0
* Thirty-two rats which had hexoestrol (0.4 mg/kg) subcutaneously for 4-6 days.
The results are summarised in Table 2. In contrast to the experiments in
which amphenone was fed, corticosterone secretion was reduced to about
one-half by approximately 50 mg/kg intravenous amphenone. It thus
appears that not the species but the mode of administration was responsible
for the inhibition of steroid synthesis experienced in the one and the stimu-
lation experienced in the other type of experiment. It is of some interest to
note that the intravenous amphenone was very poorly tolerated by the rats,
and that infusion of large volumes of 0.9 per cent NaCi solution was
required to keep the rats alive and their blood pressure at a safe level. A fall
in blood pressure is also reported by Thorn et al.' in a patient who was
given amphenone by the mouth. Whether the inhibition following intra-
venous amphenone is only a result of overdosage was checked by repeating
the experiments with smaller amounts. Four infusions were carried out,
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and the doses of amphenone used were 3.3, 5, 10, and 11 mg/kg. The blood
pressure was kept steady by infusion of rat blood whenever required. Small
decreases in secretion of between 10 per cent and 15 per cent were observed,
changes which hardly exceed accidental variations. There did not appear to
exist a dose range at which increased secretion, as seen in the feeding
experiments, occurred.
Since the effects of hexoestrol on corticosterone production and lipid
storage in the adrenal are the opposite of those of amphenone, an attempt
was made to restore the secretory depression and lipid loss due to hex-
oestrol by administering amphenone. All rats were first given four injec-
tions of hexoestrol, a treatment of sufficient duration to cause loss of lipids
from all cortical layers except the glomerulosa and severe depression of
secretory capacity. The hexoestrol injections were then combined with daily
oral doses of amphenone for periods ranging from 4-12 days (Table 3). In
all these rats, lipids were deposited in the fasciculata so that the glands
would have appeared like normal glands, had it not been for the hypertrophy
and for the enlarged blood vessels in the zona reticularis. Secretion was
restored to normal in all rats in which the combined treatment did not
exceed four days (see also column 6, Fig. 2), whereas longer duration of
the combined treatment led to normal figures per g gland in four and sub-
normal figures in three rats. It is, however, obvious that even in those ani-
mals in which secretion per g adrenal did not attain normal figures, secre-
tion per kg bodyweight was far above that of rats to which hexoestrol alone
had been administered. A striking feature of the combined treatment with
hexoestrol and amphenone was that it invariably produced jaundice,
whereas jaundice was not observed in rats given either compound alone.
Any attempt at interpreting the mode of action of amphenone will have
to take into consideration the effects of ACTH on adrenal secretory capac-
ity and on cortical morphology. The release of ACTH by amphenone can-
not, as with hexoestrol, be interpreted as due to low levels of circulating
cortical hormone, but is probably a consequence of the toxicity of the com-
pound. There can, however, be no doubt about its release; it is suggested by
the hypertrophy of the gland, its increase in vascularity and the demonstra-
tion by Hertz and Tullner9 that hypophysectomized, ACTH-maintained rats
do not exhibit adrenal changes when fed with amphenone.
On comparing the effects of four days' feeding with amphenone and four
days' injections of ACTH' (12 hourly injections of 1 u. Cortrophin Z,
Organon, a 'delayed action-ACTH,' subcutaneously), lipid accumulation
was found to be about the same, whether ACTH or amphenone had been
given. When treatment was prolonged, lipid deposition became more ex-
cessive with amphenone than with ACTH. In the experiments which lasted
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four days, ACTH caused an increase in corticosterone secretion (per kg
bodyweight) of approximately 50 per cent, whereas amphenone caused an
increase of 150 per cent. Since, in such short experiments, changes in
dosage and timing of the ACTH injections did not appear to increase the
secretory performance any further, one might suspect an effect of am-
phenone on adrenal metabolism in addition to its capacity of releasing
ACTH. In vitro effects have so far only been described as inhibitory,"'7
but the possibility that smaller doses might stimulate some phase of
synthesis has not yet been explored.
SUMMARY
Adrenal secretory capacity was measured in rats by estimating the corti-
costerone secreted by the left adrenal during operative stress after the
production of lipid depletion by hexoestrol and of lipid accumulation by
amphenone.
Hexoestrol (0.4 mg/kg subcutaneously) inhibits corticosterone secretion,
and this effect begins after as short an administration as two days and
persists as long as hexoestrol is given. It is completely reversible by:
(a) Stopping the treatment
(b) An intravenous infusion of normal rat plasma
(c) Giving amphenone (0.2 g/kg by mouth) along with the hexoestrol.
Procedures (a) and (c) bring the lipid deposition in the adrenal cortex
back to normal.
When amphenone is administered (0.2 g/kg by mouth) for 2-17 days,
the secretion of corticosterone per g gland is at the upper reaches of or
above normal; secretion per gland is greatly enhanced. Large doses infused
into the femoral vein inhibit secretion. The site of action of amphenone
is discussed.
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